Nasdaq - Delayed Quote USD

Eventide Healthcare & Life Sciences N (ETNHX)

33.09 +0.42 (+1.29%)
At close: April 26 at 8:00 PM EDT

Investment Information

Min Initial Investment
100,000
Min Initial Investment, IRA
--
Min Initial Investment, AIP
1,000
Min Subsequent Investment
100,000
Min Subsequent Investment, IRA
--
Min Subsequent Investment, AIP
1

Broker Availability

  • Ameriprise Brokerage
  • Ameriprise SPS Advantage
  • Raymond James
  • Raymond James WRAP Eligible
  • Commonwealth Universe
  • TD Ameritrade Retail
  • TD Ameritrade Institutional
  • Securities America Advisors
  • Securities America Inc.
  • Ameriprise SPS Advisor
  • Kestra Financial
  • Commonwealth (PPS Access Program)
  • Commonwealth (NTF - PPS/Advisory)
  • Commonwealth (PPS/Advisory)
  • LPL Brokerage Availability - February 2024

Fund Summary

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

Fund Overview

Category Health
Fund Family Eventide Funds
Net Assets 1.72B
YTD Return 4.67%
Yield 0.00%
Morningstar Rating
Inception Date Dec 27, 2012

Performance & Risk

YTD Return -8.57%
5y Average Return 2.44%
Rank in Category (ytd) 70
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.70
Morningstar Risk Rating

Related Tickers